Dailypharm Live Search Close

Will restrictions be eased for vaccine clinical trials?

By Lee, Jeong-Hwan | translator Kim, Jung-Ju

23.10.25 16:12:48

°¡³ª´Ù¶ó 0
Current regulations recommend 10%... Rep. Ki-Youn Kang said, ¡°Vaccine development can be pulled forward 3 years if the mandatory Korean proportion of subjects is reduced to 5%¡±

MFDS promises improvement in response to NA criticism... to secure vaccine sovereignty over domestically produced vaccines and increase self-sufficiency


Minister of Food and Drug Safety Yu-Kyung Oh promised to reduce or ease the mandatory participation rate of domestic clinical patients from the current 10% to 5% to strengthen sovereignty over domestically produced vaccines and increase self-sufficiency.

The plan is to improve the current regulations by accepting the claims raised by domestic pharmaceutical companies that seek to develop domestic vaccines and agreeing with the National Assembly's suggestion to speed up development by lowering the domestic reference rate to reinforce actual vaccine self-sufficiency.

On the 25th, Yu-Kyung Oh, Minister of Food and Drug Safety, responded as follows to an on-site inquiry made by Rep. Ki-Youn

Lee, Jeong-Hwan(junghwanss@dailypharm.com)
If you want to see the full article, please JOIN US (click)